Blood Neurofilament Light Chain in Parkinson’s Disease: Comparability between Parkinson’s Progression Markers Initiative (PPMI) and Asian Cohorts
出版年份 2021 全文链接
标题
Blood Neurofilament Light Chain in Parkinson’s Disease: Comparability between Parkinson’s Progression Markers Initiative (PPMI) and Asian Cohorts
作者
关键词
-
出版物
Journal of Clinical Medicine
Volume 10, Issue 21, Pages 5085
出版商
MDPI AG
发表日期
2021-11-02
DOI
10.3390/jcm10215085
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- To Adjust or Not to Adjust? When a “Confounder” Is Only Measured After Exposure
- (2021) Rolf H. H. Groenwold et al. EPIDEMIOLOGY
- Intraindividual Neurofilament Dynamics in Serum Mark the Conversion to Sporadic Parkinson's Disease
- (2020) Carlo Wilke et al. MOVEMENT DISORDERS
- CSF NFL in a Longitudinally Assessed PD Cohort: Age Effects and Cognitive Trajectories
- (2020) Stefanie Lerche et al. MOVEMENT DISORDERS
- Serum neurofilament light chain levels reflect cortical neurodegeneration in de novo Parkinson's disease
- (2020) Frederic Sampedro et al. PARKINSONISM & RELATED DISORDERS
- Utility of plasma Neurofilament light as a diagnostic and prognostic biomarker of the postural instability gait disorder motor subtype in early Parkinson’s disease
- (2020) Adeline Su Lyn Ng et al. Molecular Neurodegeneration
- Is There a Value of Neurofilament Light as a Biomarker for Neurodegeneration in Parkinson's Disease?
- (2020) Henrik Zetterberg MOVEMENT DISORDERS
- Serum neurofilament light as a biomarker in progressive multiple sclerosis
- (2020) Raju Kapoor et al. NEUROLOGY
- Development of an assay of plasma neurofilament light chain utilizing immunomagnetic reduction technology
- (2020) Huei-Chun Liu et al. PLoS One
- Acute Neurofilament Light Chain Plasma Levels Correlate With Stroke Severity and Clinical Outcome in Ischemic Stroke Patients
- (2020) Helle H. Nielsen et al. Frontiers in Neurology
- Current and projected future economic burden of Parkinson’s disease in the U.S.
- (2020) Wenya Yang et al. npj Parkinsons Disease
- Validation of Serum Neurofilament Light Chain as a Biomarker of Parkinson’s Disease Progression
- (2020) Brit Mollenhauer et al. MOVEMENT DISORDERS
- CSF Neurofilament Light Chain Elevation Predicts ALS Severity and Progression
- (2020) Qionghua Sun et al. Frontiers in Neurology
- Equivalence of serum and plasma neurofilament light chain levels using highly sensitive automated immunoassay
- (2020) Xiaolei Qiu et al. Alzheimers & Dementia
- Serum NFL discriminates Parkinson disease from atypical parkinsonisms
- (2019) Tainá M. Marques et al. NEUROLOGY
- Diagnostic Value of Cerebrospinal Fluid Neurofilament Light Protein in Neurology
- (2019) Claire Bridel et al. JAMA Neurology
- Blood NfL
- (2019) Chin-Hsien Lin et al. NEUROLOGY
- CSF or serum neurofilament light added to α‐Synuclein panel discriminates Parkinson's from controls
- (2019) Linda P. Oosterveld et al. MOVEMENT DISORDERS
- Integrated Plasma and Neuroimaging Biomarkers Associated with Motor and Cognition Severity in Parkinson’s Disease
- (2019) Chih-Hao Chen et al. Journal of Parkinsons Disease
- Parkinson’s Disease: Biomarkers, Treatment, and Risk Factors
- (2018) Fatemeh N. Emamzadeh et al. Frontiers in Neuroscience
- Global, regional, and national burden of Parkinson's disease, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016
- (2018) E. Ray Dorsey et al. LANCET NEUROLOGY
- Levels of plasma neurofilament light chain and cognitive function in patients with Alzheimer or Parkinson disease
- (2018) Yung-Shuan Lin et al. Scientific Reports
- Blood-based NfL
- (2017) Oskar Hansson et al. NEUROLOGY
- Clinical Neurology and Epidemiology of the Major Neurodegenerative Diseases
- (2017) Michael G. Erkkinen et al. Cold Spring Harbor Perspectives in Biology
- Parkinson disease
- (2017) Werner Poewe et al. Nature Reviews Disease Primers
- Clinical effectiveness and cost-effectiveness of physiotherapy and occupational therapy versus no therapy in mild to moderate Parkinson’s disease: a large pragmatic randomised controlled trial (PD REHAB)
- (2016) Carl E Clarke et al. HEALTH TECHNOLOGY ASSESSMENT
- Parkinson's disease-related increase of T2*-weighted hypointensity in substantia nigra pars compacta
- (2016) Jason Langley et al. MOVEMENT DISORDERS
- Loss of Nigral Hyperintensity on 3 Tesla MRI of Parkinsonism: Comparison With123I-FP-CIT SPECT
- (2016) Yun Jung Bae et al. MOVEMENT DISORDERS
- The Impact of DaTscan in the Diagnosis of Parkinson Disease
- (2015) Isis Gayed et al. CLINICAL NUCLEAR MEDICINE
- Automated Neuromelanin Imaging as a Diagnostic Biomarker for Parkinson's Disease
- (2015) Gabriel Castellanos et al. MOVEMENT DISORDERS
- Dopamine transporter imaging as a diagnostic tool for parkinsonism and related disorders in clinical practice
- (2015) Fang Ba et al. PARKINSONISM & RELATED DISORDERS
- The ‘Swallow Tail’ Appearance of the Healthy Nigrosome – A New Accurate Test of Parkinson's Disease: A Case-Control and Retrospective Cross-Sectional MRI Study at 3T
- (2014) Stefan T. Schwarz et al. PLoS One
- A comparison of confounding adjustment methods with an application to early life determinants of childhood obesity
- (2014) L. Li et al. Journal of Developmental Origins of Health and Disease
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now